ALLMedicine™ Agammaglobulinemia Center
Research & Reviews 479 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962096
Oncology Reports; Kim JM, Park J et. al.
Mar 24th, 2021 - Bruton's agammaglobulinemia tyrosine kinase (BTK) is an important cytoplasmic tyrosine kinase involved in B‑lymphocyte development, differentiation, and signaling. Activated protein kinase C (PKC), in turn, induces the activation of mitogen‑activa...
https://doi.org/10.1007/s10875-021-01017-3 10.1038/361226a0 10.1006/clim.2002.5241 10.1034/j.1600-065X.2000.17809.x 10.1046/j.1365-2141.2001.02905.x 10.1097/01.md.0000229482.27398.ad 10.1016/j.jaip.2015.12.015 10.1016/j.jaci.2020.03.001 10.5114/aoms.2016.60338 10.1016/S0147-9571(02)00051-6 10.1111/ped.13453 10.1016/j.clim.2019.108328 10.1093/bioinformatics/bty897 10.1038/nmeth.2890 10.1016/j.gene.2015.02.019 10.1016/B978-0-12-404748-8.00009-5 10.1007/BF03401778 10.1093/hmg/3.10.1751 10.1073/pnas.91.19.9062 10.1126/scisignal.2004298 10.1074/jbc.M104828200 10.7554/eLife.06074 10.1007/s10875-019-00737-x 10.1093/mmy/myy136 10.1097/MOP.0000000000000031 10.3389/fimmu.2018.02337 10.1038/s41598-017-06342-5 10.1111/j.1600-0854.2012.01382.x 10.1016/j.mib.2020.07.001 10.3389/fimmu.2017.01454 10.1093/cid/cix687 10.1182/blood-2017-11-818286 10.1093/cid/ciy175 10.1016/j.waojou.2019.100018 10.1182/blood-2010-04-281170 10.1016/j.semcdb.2018.03.020 10.3324/haematol.2019.219220 10.3324/haematol.2016.152017 10.1080/1040841X.2020.1751060 10.1186/s12879-019-3941-3 10.1128/JCM.01646-10 10.1099/jmm.0.062174-0 10.1128/JCM.05095-11 10.4103/ijo.IJO_389_18 10.1099/jmmcr.0.000044 10.1080/23744235.2016.1239027 10.1155/2019/6253829 10.12932/AP0304.31.4.2013
Journal of Clinical Immunology; Chear CT, Nallusamy R et. al.
Mar 13th, 2021 - X-linked agammaglobulinemia is a rare primary immunodeficiency due to a BTK mutation. The patients are characteristically deficient in peripheral B cells and serum immunoglobulins. While they are susceptible to infections caused by bacteria, enter...
https://doi.org/10.1097/INF.0000000000003056
The Pediatric Infectious Disease Journal; Fettinger NB, Bradley JS et. al.
Mar 12th, 2021 - Metagenomic next-generation sequencing is a promising tool for detecting pathogens that are difficult to isolate by traditional modalities, particularly in the diagnosis of complex infections in immunocompromised children. We describe a child with...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912932
The American Journal of Case Reports; Almontasheri A, Al-Husayni F et. al.
Feb 22nd, 2021 - BACKGROUND Since the emergence of coronavirus disease 2019 (COVID-19), patients with the illness have presented with considerable variation in severity. Some infected individuals present mild or no symptoms, while others present severe illness wit...
https://doi.org/10.1016/j.jaci.2021.01.027
The Journal of Allergy and Clinical Immunology; Kury P, Staniek J et. al.
Feb 11th, 2021 - Agammaglobulinemia with normal B-cell numbers in a patient lacking Bob1.|2021|Kury P,Staniek J,Wegehaupt O,Janowska I,Eckenweiler M,|
Drugs 39 results see all →
Clinicaltrials.gov 541 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962096
Oncology Reports; Kim JM, Park J et. al.
Mar 24th, 2021 - Bruton's agammaglobulinemia tyrosine kinase (BTK) is an important cytoplasmic tyrosine kinase involved in B‑lymphocyte development, differentiation, and signaling. Activated protein kinase C (PKC), in turn, induces the activation of mitogen‑activa...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9d42adca-0dd7-4df7-864d-5a7feee52130
Mar 21st, 2021 - GAMMAGARD LIQUID is indicated as replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients two years of age or older. This includes, but is not limited to, common variable immunodeficiency (CVID), X-linked agamm...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9aad7ec9-6097-4805-8f1b-898bec35f218
Mar 21st, 2021 - CUVITRU is an Immune Globulin Subcutaneous (Human) (IGSC), 20% Solution indicated as replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients two years of age and older. This includes, but is not limited to, co...
https://doi.org/10.1007/s10875-021-01017-3 10.1038/361226a0 10.1006/clim.2002.5241 10.1034/j.1600-065X.2000.17809.x 10.1046/j.1365-2141.2001.02905.x 10.1097/01.md.0000229482.27398.ad 10.1016/j.jaip.2015.12.015 10.1016/j.jaci.2020.03.001 10.5114/aoms.2016.60338 10.1016/S0147-9571(02)00051-6 10.1111/ped.13453 10.1016/j.clim.2019.108328 10.1093/bioinformatics/bty897 10.1038/nmeth.2890 10.1016/j.gene.2015.02.019 10.1016/B978-0-12-404748-8.00009-5 10.1007/BF03401778 10.1093/hmg/3.10.1751 10.1073/pnas.91.19.9062 10.1126/scisignal.2004298 10.1074/jbc.M104828200 10.7554/eLife.06074 10.1007/s10875-019-00737-x 10.1093/mmy/myy136 10.1097/MOP.0000000000000031 10.3389/fimmu.2018.02337 10.1038/s41598-017-06342-5 10.1111/j.1600-0854.2012.01382.x 10.1016/j.mib.2020.07.001 10.3389/fimmu.2017.01454 10.1093/cid/cix687 10.1182/blood-2017-11-818286 10.1093/cid/ciy175 10.1016/j.waojou.2019.100018 10.1182/blood-2010-04-281170 10.1016/j.semcdb.2018.03.020 10.3324/haematol.2019.219220 10.3324/haematol.2016.152017 10.1080/1040841X.2020.1751060 10.1186/s12879-019-3941-3 10.1128/JCM.01646-10 10.1099/jmm.0.062174-0 10.1128/JCM.05095-11 10.4103/ijo.IJO_389_18 10.1099/jmmcr.0.000044 10.1080/23744235.2016.1239027 10.1155/2019/6253829 10.12932/AP0304.31.4.2013
Journal of Clinical Immunology; Chear CT, Nallusamy R et. al.
Mar 13th, 2021 - X-linked agammaglobulinemia is a rare primary immunodeficiency due to a BTK mutation. The patients are characteristically deficient in peripheral B cells and serum immunoglobulins. While they are susceptible to infections caused by bacteria, enter...
https://doi.org/10.1097/INF.0000000000003056
The Pediatric Infectious Disease Journal; Fettinger NB, Bradley JS et. al.
Mar 12th, 2021 - Metagenomic next-generation sequencing is a promising tool for detecting pathogens that are difficult to isolate by traditional modalities, particularly in the diagnosis of complex infections in immunocompromised children. We describe a child with...
News 11 results
https://reference.medscape.com/viewarticle/732961_3
Jan 14th, 2020 - Which of the following is the most likely diagnosis? Your Peers Chose: Bruton agammaglobulinemia 0% Thymoma 0% Pheochromocytoma 0% Teratoma 0% Discussion The patient in this case was eventually diagnosed with thymoma. Symptoms from a thymoma or th...
https://www.medscape.com/viewarticle/915280
Jul 4th, 2019 - The US Food and Drug Administration (FDA) has approved a 20% immune globulin solution for subcutaneous injection (Xembify, Grifols) to treat primary immunodeficiencies in patients as young as 2 years old, according to a company statement. The appr...
https://www.mdedge.com/hematology-oncology/article/186860/anemia/fda-approves-ivig-product-pi-and-chronic-itp
HT Staff
Feb 9th, 2017 - Vials of product Photo by Bill Branson The US Food and Drug Administration (FDA) has approved an intravenous immunoglobulin (IVIG) product (Gammaplex® 10%) for the treatment of primary immunodeficiency (PI) and chronic immune thrombocytopenia (ITP.
https://www.mdedge.com/hematology-oncology/article/187717/pediatrics/fda-approves-ivig-product-kids
HT Staff
Aug 7th, 2015 - Vials of drug Photo by Bill Branson The US Food and Drug Administration (FDA) has approved an intravenous human immune globulin (IVIG) product (Gammaplex) for pediatric patients age 2 years and older who have primary humoral immunodeficiencies. Th.
https://www.medscape.com/viewarticle/729411
Sep 23rd, 2010 - September 24, 2010 — Octapharma USA is voluntarily withdrawing all lots of immune globulin G (IgG) intravenous (human) 5% liquid preparation (Octagam) in the United States while it investigates blood clots and embolisms linked with the biologic, t...